AASLD-TASL Digital Hepatology Connect

Dear Colleagues,

It is with great pleasure that the American Association for the Study of Liver Diseases (AASLD) and the Turkish Association for the Study of the Liver (TASL) announce our second joint conference to CONNECT physicians and health care providers in Turkey with experts from the USA and Turkey in hepatology.

AASLD is the global leader focused on advancing the science and practice of hepatology. Content delivered from our programs and journals, combined with local perspectives from experts in Turkey, have facilitated the incorporation of cutting edge research data into practice and offer the best possible atmosphere to encourage collaborative research between Turkish and American physicians.

This year, we have decided to take on the current challenges presented by the ongoing pandemic head-on and created a unique and exciting collaborative opportunity to link two meetings into a seamless, productive interactive experience. AASLD and TASL are working together to offer TASL attendees in our joint AASLD-TASL Digital Hepatology Connect to also register (at no additional cost) for The Liver Meeting Digital Experience™ 2020.

We truly believe that this arrangement for TASLD audience to participate in the two meetings will maximize learning about the latest liver disease research being presented at The Liver Meeting Digital Experience,™ followed, with the Hepatology Connect, by bringing the knowledge to life with more in-depth, case study-based discussions for state-of-the-art diagnosis and treatment approaches. The opportunity to interact with the unprecedented number of AASLD faculty and with local and regional experts in the science and practice of hepatology will make this a must-attend combination of events for the TASL audience.

We would be grateful to partner with organizations and companies that share our vision of collaboration and exchange. Support of this meeting is vital so that we can provide attendees with a quality meeting experience. Specifically, your support will help us deliver an exceptional scientific program via a digital platform that allows for large didactic lectures and smaller breakout sessions, as well as other opportunities for faculty and attendees to interact. Your participation will be mutually beneficial. There will be opportunities for satellite symposia and virtual exhibition space, and your involvement will provide exposure and brand recognition to extend your reach to hundreds of attendees.

On behalf of AASLD and TASL, we would like to thank you in advance for your financial contribution. Your support will play a crucial role in promoting liver health, providing quality patient care, and advancing the study and practice of hepatology in the region, especially in the area of viral hepatitis, chronic liver disease and hepatocellular carcinoma. It is because of supporters like you that we are able to plan and implement programs of this magnitude and collaboration on a global level. Your generosity directly allows us to carry out our mission to prevent and ultimately cure liver disease in Turkey, the US, and the world over.

Sincerely,